Active specific immunoprophylaxis of influenza in the context of the COVID-19 pandemic and the beginning of vaccination against coronavirus infection caused by the SARS-CoV-2 virus

A literature review based on the analysis of data published in the open press or available in electronic form on the official websites of international and national professional medical communities, as well as government regulatory bodies, is devoted to the issues of influenza immunization in the context of the COVID-19 pandemic and the start of vaccination against coronavirus infection caused by the SARS-CoV-2 virus. It is emphasized that influenza vaccinations significantly reduce the incidence and frequency of severe forms of influenza infection, which is accompanied by a decrease in the burden on the healthcare system and the preservation of reserves to combat the COVID-19 pandemic. Preliminary data are presented on the positive impact of influenza immunization on the incidence, severity and outcome of COVID-19, especially in people over the age of 65. Changes were noted in the National Immunization Schedule aimed at increasing coverage with influenza vaccinations, as well as at the start of vaccination against coronavirus infection caused by the SARS-CoV-2 virus, with the allocation of priority populations for priority immunization.